Merck & Co Inc

NYSE:MRK  
72.65
-1.97 (-2.64%)
4:12:06 PM EDT: $72.73 +0.08 (+0.11%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)178.88B
Current PE25.26
Forward PE 11.25
2yr Forward PE 10.33
See more stats
Estimates Current Quarter
Revenue$12.66 Billion
Adjusted EPS$1.62
See more estimates
10-Day MA$74.20
50-Day MA$78.66
200-Day MA$79.31
See more pivots

Merck & Co., Inc. Stock, NYSE:MRK

2000 Galloping Hill Road, Kenilworth, New Jersey 07033
United States of America
Phone: +1.908.740.4000
Number of Employees: 71000

Description

Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock and companion animal species. The Healthcare Services segment offers services and solutions that focus on engagement, health analytics, and clinical services to improve the value of care delivered to patients. The Alliances segment includes results from the company's relationship with AstraZeneca LP related to sales of Nexium and Prilosec. The company was founded in 1891 and is headquartered in Kenilworth, NJ.